FDA's draft guidance on laboratory‐developed tests increases clinical and economic risk to adoption of pharmacogenetic testing. (July 2015) - Levy, Kenneth D.; Pratt, Victoria M.; Skaar, Todd C.; Vance, Gail H.; Flockhart, David A.